[SYRE] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
07-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -77.74%
YoY- -72.11%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 CAGR
Revenue 0 0 174 1,399 -
PBT -69,010 -40,104 -18,443 -20,281 50.35%
Tax -18 3 -209 26 -
NP -69,028 -40,107 -18,234 -20,307 50.30%
Tax Rate - - - - -
Total Cost 69,028 40,107 18,408 21,706 47.00%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 CAGR
NP Margin 0.00 0.00 -10,479.31 -1,451.54 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 CAGR
EPS -1.36 -9.34 -4.84 -7.72 -43.91%
EPS Diluted -1.36 -9.34 -4.84 -7.72 -43.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.